I. General considerations
Nuclear magnetic resonance (NMR) spectra were obtained using either a Bruker AVANCE-III-300 operating at 300. experiments. The 13 C shifts were obtained from proton-decoupled 13 C NMR spectra. Where necessary, the multiplicities of the 13 C signals were deduced from proton-decoupled DEPT-135 spectra. The resonances of the proton-bearing carbon atoms were correlated with specific proton resonances using 2D ( 13 C-1 H) heteronuclear single-quantum coherence (HSQC) experiments. Standard Bruker pulse programs were used in the experiments. Single crystal X-ray diffraction data were collected on a Bruker D8 Venture with Apex3 and a Photon 100 CMOS detector (2 -5) or a Bruker Apex II with a CCD detector (6) using Mo-K  radiation ( = 0.71073 Å) (Iµs, 2 -5; sealed tube, 6). Crystals were selected under paratone oil, mounted on nylon loops then immediately placed in a cold stream of N 2 at 150 K (at 173 K for 6). Data were reduced using Bruker SAINT and SADABS, solved using Bruker SHELXTS and refined using SHELXTL (2 -5) and Olex2 (6) denotes the peaks belonging to the cationic biscarbene gold(I) complex (1) Scalebar: 20 microns. Legend: N=nucleus, DC= detached cell, F=filopodia, CN=contracted nucleus S16 Untreated A549 cells typically have an oval nucleus; when treated with 5 there was a change in the shape of many nuclei as indicated by the arrows (Fig. S19, panel e ). Although the cells appeared to be intact (Fig. S19, panel d ) many nuclei lost their typical ovioid shape.
Changes to the normal nuclear morphology is followed by cell death. Filopodia were also visible in the cells that were affected by 5. Cisplatin treated cells were more granular (indicated by the arrow in Figure S19 
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